Pediatric Nephrology and Rheumatology Practice Patterns in Granulomatosis with Polyangiitis: A Midwest Pediatric Nephrology Consortium Study
Table 3
Management of GPA with end-stage renal disease.
Survey Question
Specialty, N
Yes, %
No, %
Unsure, %
p-value
Aside from routine considerations of modality, do you PREFER Hemodialysis over Peritoneal Dialysis (PD) because of the risk of infection from immunosuppression on PD?
Rheum, 55
9.1
14.5
76.4
P=0.019
Neph, 63
17.4
74.6
7.94
Once a patient is on dialysis, do you try to taper off the immunosuppression earlier than a non-dialysis GPA patient?
Rheum, 55
5.5
36.4
58.2
<0.0001
Neph, 60
28.3
70.0
1.7
Do you wait for ANCA titer to become negative before listing for transplant?
Rheum, 55
3.6
16.4
80.0
<0.0001
Neph, 59
30.5
55.9
13.6
Do you believe ANCA titer positivity AT THE TIME OF RENAL TRANSPLANT influences graft survival or vasculitis relapse rate?
Rheum, 55
7.3
9.1
83.6
<0.0001
Neph, 58
25.8
51.7
22.4
Is your renal transplant INDUCTION immunosuppression for a patient with GPA any different than a non-GPA renal transplant patient?
Rheum, 54
3.7
3.7
92.6
<0.0001
Neph, 59
18.6
64.4
17.0
Is your renal transplant MAINTENANCE immunosuppression for a patient with GPA any different than a non-GPA renal transplant patient?
